Assessment Of Heart Team’S Treatment Decision Variability: Insights From The Syntax III Revolution Trial.
Daniele Andreini(Centro Cardiologico Monzino), Patrick W. Serruys(Erasmus MC), Paolo Olivares(Centro Cardiologico Monzino), Laurent Macron(Clinique Hartmann), Antonio L. Bartorelli(University of Milan), Laura Cavallotti(Centro Cardiologico Monzino), Francesco Maisano(Vita-Salute San Raffaele University), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Yosuke Miyazaki(Yamaguchi University), Mauro Pepi(Centro Cardiologico Monzino), Gianluca Pontone(University of Milan), Maurizio Roberto(Centro Cardiologico Monzino), Saima Mushtaq(Centro Cardiologico Monzino), Giorgia Bonalumi(Centro Cardiologico Monzino), Cristina Ferrari(Centro Cardiologico Monzino), Carlos Collet(Onze Lieve Vrouwziekenhuis Hospital)
Cited by 0
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k